On the Failure of Tumour Homogenate Injections to Simulate Quantitatively the Changes in Catalase Activity in the Tumour-Bearing Host
1961

Effects of Tumor Homogenate Injections on Catalase Activity

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): D. H. Adams

Primary Institution: London Hospital Medical College

Hypothesis

Can multiple injections of tumor homogenates simulate the changes in catalase activity observed in tumor-bearing animals?

Conclusion

Multiple injections of Sarcoma 37 homogenate produced changes in liver catalase levels that resembled but did not match those seen in tumor-bearing mice.

Supporting Evidence

  • Multiple injections of Sarcoma 37 homogenate produced a depression in liver catalase level.
  • The increase in distribution ratio was independent of dose over the range studied.
  • Total catalase activity was still 60 percent of normal compared to about 40 percent or less in tumor-bearing animals.

Takeaway

The study looked at how injecting tumor tissue affects a specific enzyme in mice, and found that it doesn't work the same way as when the mice have actual tumors.

Methodology

Young adult CBA strain mice were injected with tumor homogenates, and liver catalase activity was measured in different fractions.

Limitations

The study may not accurately simulate the tumor environment due to the use of homogenates and the maximum tolerated doses.

Participant Demographics

Young adult mice of the CBA strain.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication